Indian pharma industry continues to face headwinds: ICRA
Increased regulatory scrutiny and consolidation of supply chain in the US market resulting in pricing pressures along with…
Author
Taro Pharmaceuticals in agreement with Thallion Pharmaceuticals
To acquire all of the issued and outstanding shares of Thallion Pharmaceuticals
The Social Way to Success
India Pharma Inc needs to leverage the potential of social media to up its game in times to come
DIA to organise pharmacovigilance conference
The conference will be held in Mumbai on March 24 and 25, 2017
Indian pharma cos need to join forces to counter IP threats
A key takeaway from the 6th Annual Pharma IPR Indian 2017 was the need for concerted action among Indian pharma peers on domestic…
TA Associates invests in Ideal Cures
Ideal Cures aims to leverage TA’s networking and other corporate development capabilities to accelerate growth
Pharma industry appreciates MoHF&W’s move on National Health Policy
"National Health Policy is a forward looking policy which would revive India's healthcare system by ensuring that Indians have…
Govt gets Rs 672 Crs fine from pharma cos for overcharging
Since inception, the NPPA has issued 1,527 demand notices to companies for overcharging
Eli Lilly India launches Humalog 200U/mL KwikPen
The pen offers physicians an alternative that allows patients to inject 50 per cent less insulin volume